Intravenous and oral amiodarone for arrhythmias in children.

The response of paediatric arrhythmias to intravenous and oral flecainide. Br Heart J (1987) 1.39

Safety of antiarrhythmic drugs in children. Br Heart J (1993) 0.79

Acute hemodynamic effects of intravenous amiodarone treatment in paediatric cardiac surgical patients. Clin Res Cardiol (2008) 0.75

Management of Supraventricular Tachycardia in Infants. Paediatr Drugs (2017) 0.75

Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol (1976) 3.62

Side effects of long-term amiodarone therapy. Circulation (1983) 3.03

Adverse reactions during treatment with amiodarone hydrochloride. Br Med J (Clin Res Ed) (1983) 2.43

Amiodarone pharmacokinetics. Am Heart J (1983) 2.42

Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J (1981) 2.41

High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite: methodology and preliminary observations. Ther Drug Monit (1982) 1.31

Amiodarone treatment of critical arrhythmias in children and young adults. J Am Coll Cardiol (1984) 1.23

Amiodarone in the treatment of cardiac arrhythmias in children: one hundred thirty-five cases. Am Heart J (1980) 1.11

Ocular effects in long-term amiodarone therapy. Am Heart J (1983) 0.90

Amiodarone in control of sustained tachyarrhythmias in children with Wolff-Parkinson-White syndrome. Pediatrics (1983) 0.82

Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity (1995) 10.59

Open access echocardiography in management of heart failure in the community. BMJ (1995) 7.83

Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99

Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture. Am J Hum Genet (1979) 5.18

Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet (1998) 4.91

Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science (1977) 4.59

Torsade De Pointes, an atypical ventricular tachycardia. Br Heart J (1976) 4.22

Heritable fragile sites on human chromosomes II. Distribution, phenotypic effects, and cytogenetics. Am J Hum Genet (1979) 4.10

Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet (2001) 3.83

Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation (1991) 3.70

Dynamic mutations: a new class of mutations causing human disease. Cell (1992) 3.63

Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ (1996) 3.59

Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55

Nomenclature and classification of congenital heart disease. Br Heart J (1979) 3.46

Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42

Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet (1976) 3.41

Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr (2000) 3.36

Incidence and origin of "null" alleles in the (AC)n microsatellite markers. Am J Hum Genet (1993) 3.18

A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (1995) 3.15

Side effects of long-term amiodarone therapy. Circulation (1983) 3.03

Fatal overdosage with disopyramide. Lancet (1978) 2.96

Smoking and decreased fertilisation rates in vitro. Lancet (1992) 2.92

Echocardiographic and anatomical correlations in fetal congenital heart disease. Br Heart J (1984) 2.79

CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell (1993) 2.73

Nitric oxide synthase activities in human myocardium. Lancet (1993) 2.72

Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol (2000) 2.66

A comparison of nifedipine once daily (Adalat LA), isosorbide mononitrate once daily, and isosorbide dinitrate twice daily in patients with chronic stable angina. Int J Cardiol (1996) 2.58

DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 2.56

Importance of microdeletions of chromosomal region 22q11 as a cause of selected malformations of the ventricular outflow tracts and aortic arch: a three-year prospective study. J Pediatr (1996) 2.50

Conference report: International Workshop on the fragile X and X-linked mental retardation. Am J Med Genet (1984) 2.49

Purchasing 'legal highs' on the Internet--is there consistency in what you get? QJM (2010) 2.43

Amiodarone pharmacokinetics. Am Heart J (1983) 2.42

Unnecessary x ray examinations. BMJ (1989) 2.37

Aortic valve repair of congenital stenosis with bovine pericardium. Ann Thorac Surg (1997) 2.37

Simple repeat DNA is not replicated simply. Nat Genet (1994) 2.37

Echocardiographic and anatomical correlates in the fetus. Br Heart J (1980) 2.27

Comparison of two strategies for myocardial management during coronary artery operations. Ann Thorac Surg (1994) 2.21

Transcatheter embolization in the treatment of coronary artery fistulas. J Am Coll Cardiol (1991) 2.17

Prenatal screening for congenital heart disease. Br Med J (Clin Res Ed) (1986) 2.14

X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28. Hum Genet (1979) 2.12

Ventricular septal defects. Two dimensional echocardiographic and morphological correlations. Br Heart J (1982) 2.11

Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients. European Cooperative Study Group. Eur Heart J (1993) 2.10

Assignment of anonymous DNA probes to specific intervals of human chromosomes 16 and X. Hum Genet (1989) 2.10

Obstetric importance, diagnosis, and management of fetal tachycardias. BMJ (1988) 2.07

Dynamic mutation: possible mechanisms and significance in human disease. Trends Biochem Sci (1997) 2.04

Measuring brain natriuretic peptide. Lancet (1996) 2.03

Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01

Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. Genomics (1992) 2.00

Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J (2003) 1.99

Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers. Am J Hum Genet (1991) 1.95

Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet (1992) 1.91

Heritable fragile sites on human chromosomes. V. A new class of fragile site requiring BrdU for expression. Am J Hum Genet (1980) 1.88

Rehydration in the treatment of severe hypercalcaemia. Q J Med (1981) 1.87

Pulmonary atresia with intact ventricular septum: impact of fetal echocardiography on incidence at birth and postnatal outcome. UK and Eire Collaborative Study of Pulmonary Atresia with Intact Ventricular Septum. Circulation (1998) 1.87

bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene (1996) 1.87

Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem (2001) 1.86

Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet (1995) 1.86

Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci U S A (1999) 1.86

LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity (1997) 1.85

Policy for prevention of Asian rickets in Britain: a preliminary assessment of the Glasgow rickets campaign. Br Med J (Clin Res Ed) (1981) 1.83

Explanation for exclusive maternal origin for congenital form of myotonic dystrophy. Lancet (1993) 1.72

Fragile X syndrome: genetic localisation by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site. J Med Genet (1991) 1.71

Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol (1999) 1.70

Primary cardiac tumours in childhood. Arch Dis Child (1971) 1.70

Mapping the short arm of human chromosome 16. Genomics (1989) 1.69

Developments in interventional catheterisation and progress in surgery for congenital heart disease: achieving a balance. Br Heart J (1993) 1.68

The natural history of the hypoplastic left heart syndrome. Int J Cardiol (1989) 1.67

Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology (2003) 1.67

The detection of fat embolism by transoesophageal echocardiography during reamed intramedullary nailing. A study of 24 patients with femoral and tibial fractures. J Bone Joint Surg Br (1993) 1.66

Anatomical basis of cross sectional echocardiography. Br Heart J (1983) 1.63

Down's syndrome in South Australia. Med J Aust (1979) 1.63

The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol (1994) 1.63

Diagnosis of atrial situs by transesophageal echocardiography. J Am Coll Cardiol (1990) 1.62

Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome (2001) 1.62

Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet (1996) 1.61

Intrapulmonary arteriovenous shunting may be a universal phenomenon in patients with the superior cavopulmonary anastomosis: a radionuclide study. Heart (2000) 1.59

Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol (1994) 1.59

Evaluation of fetal arrhythmias by echocardiography. Br Heart J (1983) 1.59

Prevention of rickets in Asian children: assessment of the Glasgow campaign. Br Med J (Clin Res Ed) (1985) 1.58

Role of nitric oxide synthesis in the regulation of coronary vascular tone in the isolated perfused rabbit heart. Cardiovasc Res (1992) 1.57

Partial and complete trisomy 9: delineation of a trisomy 9 syndrome. Hum Genet (1976) 1.56

Transesophageal echocardiographic monitoring of interventional cardiac catheterization in children. J Am Coll Cardiol (1991) 1.56

Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene (1998) 1.56

Pulmonary atresia with intact ventricular septum: predictors of early and medium-term outcome in a population-based study. J Thorac Cardiovasc Surg (2005) 1.55

Fine mapping of gene probes and anonymous DNA fragments to the long arm of chromosome 16. Genomics (1988) 1.55

Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell (1997) 1.55

Heritable fragile sites on human chromosomes. VII. Children homozygous for the BrdU-requiring fra(10)(q25) are phenotypically normal. Am J Hum Genet (1981) 1.55

Balloon dilatation of the aortic valve in the fetus: a report of two cases. Br Heart J (1991) 1.54

Increased plasma endothelin levels in angina patients with rapid coronary artery disease progression. Eur Heart J (2001) 1.54

Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J (1994) 1.52

Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res (1999) 1.52

Heritable fragile sites on human chromosomes. III. Detection of fra(X)(q27) in males with X-linked mental retardation and in their female relatives. Hum Genet (1979) 1.51

Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science (1994) 1.51

At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer (1994) 1.50

Catheter interventions for congenital heart disease in third world countries. Pediatr Cardiol (2005) 1.50

High frame rate myocardial integrated backscatter. Does this change our understanding of this acoustic parameter? Eur J Echocardiogr (2000) 1.49

The fragile X chromosome. Int Rev Cytol (1983) 1.49

Right ventricular function and exercise performance late after primary repair of tetralogy of Fallot with the transannular patch in infancy. Am J Cardiol (1998) 1.49

Embolisation procedures in congenital heart disease. Br Heart J (1985) 1.48